EKSO Q4 2023 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5M+36.5% YoY

Gross Profit

$2M48.9% margin

Operating Income

-$3M-71.2% margin

Net Income

-$3M-66.3% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$553,000

Balance Sheet

Total Assets

$29M

Total Liabilities

$16M

Stockholders' Equity

$13M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+36.5%
Gross Profit	$2M	$2M	+41.2%
Operating Income	-$3M	-$4M	+22.2%
Net Income	-$3M	-$3M	-1.1%

Revenue Segments

Product

$11M77%

Service

$2M15%

Subscription

$722,0005%

Product and Service, Other

$303,0002%

Geographic Segments

POLAND

$626,000100%